Brief: Median Technologies Updates On Ibiopsy Lung Cancer Screening CADX1

Median Technologies SA

06/09/2021 16:54

Sept 6 (Reuters) - Median Technologies SA  ALMDT.PA :
    * MEDIAN TECHNOLOGIES SA - MEDIAN TECHNOLOGIES ANNOUNCES OUTSTANDING
PERFORMANCE
FOR ITS IBIOPSY® LUNG CANCER SCREENING CADX1 TO ACCURATELY CHARACTERIZE
MALIGNANT VERSUS BENIGN LUNG NODULES BASED ON A LARGE-SCALE PATIENT COHORT
    * MEDIAN TECHNOLOGIES SA - FURTHER RESULTS ON A FULLY AUTOMATED END-TO-END
LUNG
CANCER SCREENING CADE/CADX INCLUDING NODULE DETECTION AND CHARACTERIZATION ARE
EXPECTED IN Q4, 2021

Source text for Eikon:  ID:nBwb0q3BVa 
Further company coverage:  ALMDT.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))